[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"ventricular-premature-complexes\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:ventricular-premature-complexes":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,53,87],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":34,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":41,"lastUpdatePostDateStruct":42,"startDateStruct":45,"completionDateStruct":47,"leadSponsor":49,"locationsCount":52},"100594377","clinical-safety-and-efficacy-testing-of-a-medical-device-kardi-ai-an-ecg-telemetry-monitoring-system-100594377",false,"NCT07018648","Clinical Safety and Efficacy Testing of a Medical Device Kardi Ai, an ECG Telemetry Monitoring System","Clinical Safety and Efficacy Testing of a Medical Device Kardi Ai, an ECG Telemetry Monitoring System Using Artificial Intelligence to Evaluate ECGs Measured by Hardware Component (POLAR H10 Chest Strap)","Kardi Ai","Inclusion Criteria:\n\n* Age above 18 years\n* Signed informed consent\u002Fwillingness to cooperate\n* Confirmed or suspected heart rhythm disorder of a cardiac rhythm disorder\n* Ability to use a smartphone and mobile app Kardi Ai\n* The subject's mobile phone meets the minimum requirements for the Kardi Ai app to work\n\nExclusion Criteria:\n\n* Confirmed pregnancy\n* Allergic reactions to standard substances used in manufacture of clothing or other textiles\n* Superficial wound or skin irritation at the site of the chest belt attachment","ALL","18 Years",{"count":20,"type":21},115,"ESTIMATED","INTERVENTIONAL",[24],"NA","The goal of this clinical trial is to evaluate the safety and efficacy of medical device Kardi Ai, an ECG telemetry monitoring device in adult population.\n\nThe main questions it aims to answer are:\n\n* What is the sensitivity and specificity of Kardi Ai device for all monitored heart rythm disorders (combined)\n* What is the sensitivity and specificity of Kardi Ai device for each of the monitored heart rythm disorders\n* What is the quality of the ECG recordings\n\nParticipants will receive Kardi Ai medical device. They will use it to collect ECG recordings from at least 5 different days and in total collect records of at least 10 hours duration.",[27,28,29,30,31,32,33],"Atrial Fibrillation (AF)","Atrial Premature Complexes","Ventricular Premature Complexes","Bradycardia","Tachycardia","Supraventricular Tachycardia","Wide QRS Tachycardia",[35,36,37,38,39],"AI","heart rhythm disorders","ECG","EKG","atrial fibrillation","RECRUITING","2025-06-10",{"date":43,"type":44},"2025-06-12","ACTUAL",{"date":46,"type":44},"2025-05-19",{"date":48,"type":21},"2025-08-30",{"name":50,"class":51},"KARDI AI Technologies s.r.o.","INDUSTRY",2,{"id":54,"slug":55,"hasResults":11,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":4,"eligibilityCriteria":59,"healthyVolunteers":11,"sex":17,"minAge":60,"maxAge":4,"enrollmentInfo":61,"targetDuration":4,"studyType":22,"phases":63,"briefSummary":64,"conditions":65,"keywords":69,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":4},"100558048","analysis-of-the-efficacy-and-stability-of-a-wearable-ecg-monitor-100558048","NCT06546046","Analysis of the Efficacy and Stability of a Wearable ECG Monitor","Analysis of the Efficacy and Stability of a Single-Channel Patch-Type Wearable Electrocardiogram Monitor","Inclusion Criteria:\n\n1. Adults aged 19 years or older\n2. Patients admitted to Chonnam National University Hospital who require ECG monitoring\n3. Individuals who have expressed their intention to participate in this study or have obtained written consent from a proxy\n\nExclusion Criteria:\n\n1. Individuals who are unable to provide consent themselves or through a legally designated representative\n2. Individuals deemed unsuitable for participation in the clinical trial based on the researcher's judgment","19 Years",{"count":62,"type":21},100,[24],"This study aims to analyze the efficacy and safety of wearable electrocardiogram (ECG) monitoring by simultaneously attaching a single-channel patch-type wearable ECG monitoring device (HiCardi+ by Mezoo Co., Ltd.) and a telemetry device (IntelliVue MX40 by Philips) used in actual wards to patients prescribed with ECG monitoring",[66,30,31,67,68,29],"Arrhythmias, Cardiac","Atrial Fibrillation","Atrial Flutter",[70,71,72,73,74,75],"Monitoring","Telemetry","Wearable device","Arrhythmia alarm","Signal loss","Satisfaction survey","NOT_YET_RECRUITING","2024-08-11",{"date":79,"type":44},"2024-08-14",{"date":81,"type":21},"2024-09-09",{"date":83,"type":21},"2025-03-30",{"name":85,"class":86},"Mezoo Co., Ltd.","OTHER",{"id":88,"slug":89,"hasResults":11,"nctId":90,"briefTitle":91,"officialTitle":91,"acronym":4,"eligibilityCriteria":92,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":93,"enrollmentInfo":94,"targetDuration":4,"studyType":96,"phases":4,"briefSummary":97,"conditions":98,"keywords":4,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":108},"100409917","personalized-treatment-for-patients-with-premature-ventricular-beats-100409917","NCT04617717","Personalized Treatment for Patients With Premature Ventricular Beats","Inclusion Criteria: Patients referred for PVC ablation","90 Years",{"count":95,"type":21},224,"OBSERVATIONAL","Frequent premature ventricular beats (PVBs) are common, negatively affects the quality of life for many patients, and can lead to impaired contractile function. Rule-out of structural heart disease is key in the assessment of PVBs. Cardiac MR has a high sensitivity for structural heart disease, but the diagnostic gain from this resource-demanding procedure in the work-up of patients with PVBs is unknown. There is a need to establish the role of MR in the evaluation of patients with PVBs to improve diagnostic efficacy, establish treatment strategies, and promote further research. This project will answer three key questions: 1) What is the diagnostic gain from cardiac MR in patients with PVBs? 2) Is MR the real gold standard to rule-out structural heart disease in patients with PVBs? 3) Can non-invasive heart rate parameters guide the strategy for induction of PVBs during invasive electrophysiological procedures?",[29],"2023-10-31",{"date":101,"type":44},"2023-11-02",{"date":103,"type":44},"2020-09-30",{"date":105,"type":21},"2040-07-31",{"name":107,"class":86},"Oslo University Hospital",1]